Akebia Therapeutics Inc
F:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
Takashimaya Co Ltd
OTC:TKSHF
|
JP |
|
L
|
LDC Dental PCL
SET:LDC
|
TH |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
H
|
Hang Lung Properties Ltd
XMUN:AOP
|
HK |
|
T
|
Toray Industries Inc
DUS:TOR1
|
JP |
|
P
|
Pax Global Technology Ltd
F:P8X
|
HK |
|
Sega Sammy Holdings Inc
F:RYU0
|
JP |
|
Concrete Pumping Holdings Inc
NASDAQ:BBCP
|
US |
|
A
|
Amdocs Ltd
XMUN:AOS
|
GG |
|
C
|
Canadian National Railway Co
XMUN:CY2
|
CA |
Intrinsic Value
Is AX9 undervalued or overvalued?
See the intrinsic value estimate for 
Akebia Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Akebia Therapeutics Does
Akebia Therapeutics is a drug company focused on kidney disease. It develops and sells prescription medicines for people with chronic kidney conditions, especially patients who have anemia tied to kidney failure or treatment. Its products are used through doctors and dialysis centers, so the company’s customers are the medical providers and health systems that prescribe and dispense the drugs to patients.
- Headquarters
- United States of America US
- Employees
- 194
- IPO date
- Mar 20, 2014
Revenue & Expenses Breakdown
Akebia Therapeutics Inc
Earnings Waterfall
Akebia Therapeutics Inc
The intrinsic value for Akebia Therapeutics Inc (AX9) under the Base Case is hidden EUR.
Compared with the current market price of 0.5994 EUR, the stock appears hidden.